These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10568897)

  • 1. Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).
    Moore AD; Joseph L
    Lupus; 1999; 8(8):612-9. PubMed ID: 10568897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of rheumatoid arthritis and systemic lupus erythematosus trial design: a commentary on ways to improve the number of positive trials in SLE.
    Miles A; Pope JE
    Clin Exp Rheumatol; 2015; 33(5):671-80. PubMed ID: 26315693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.
    Karassa FB; Tatsioni A; Ioannidis JP
    J Rheumatol; 2003 May; 30(5):979-84. PubMed ID: 12734892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring outcomes in systemic lupus erythematosus clinical trials.
    Strand V; Chu AD
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):455-68. PubMed ID: 21831027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
    Yuen SY; Pope JE
    Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier.
    Lew RA; Liang MH; Doros G
    Arthritis Res Ther; 2015 Dec; 17():345. PubMed ID: 26634344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues of corticosteroid use in SLE clinical trials.
    Corzillius M; Bae SC
    Lupus; 1999; 8(8):692-7. PubMed ID: 10568908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalence trials in SLE research: issues to consider.
    Kim MY; Buyon JP; Petri M; Skovron ML; Shore RE
    Lupus; 1999; 8(8):620-6. PubMed ID: 10568898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
    Schiffenbauer J; Simon LS
    Lupus; 2004; 13(5):398-405. PubMed ID: 15230299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size calculations for pilot randomized trials: a confidence interval approach.
    Cocks K; Torgerson DJ
    J Clin Epidemiol; 2013 Feb; 66(2):197-201. PubMed ID: 23195919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and opportunities in SLE clinical trials.
    van Vollenhoven RF
    Curr Opin Rheumatol; 2013 Sep; 25(5):606-15. PubMed ID: 23917158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies.
    Wang X; Ji X
    Chest; 2020 Jul; 158(1S):S12-S20. PubMed ID: 32658647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.